URL https://cdn.the-scientist.com/assets/articleNo/32224/iImg/5498/84388cfa-4fb0-46dc-8d75-cca6c9659dc6-1280px-takeda-pharmaceutical-company-tokyo-head-office-2.jpg
URL2 https://www.the-scientist.com/takeda-to-buy-cancer-drug-maker-ariad-for-52-billion-32224
